NI-0801 in Allergic Contact Dermatitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: NovImmune SA

Criteria

Inclusion Criteria:

• Aged ≥ 18 and ≤ 70 years

• Either male or a female lacking childbearing potential

• Previously documented nickel allergy

Exclusion Criteria:

• Any medical condition that, in the opinion of the investigator, would interfere with safe completion of the trial or that would prevent subjects from providing informed consent.

• Known or previous diagnosis of malignancy

• Known current active tuberculosis or a history of active TB within 12 months of screening

• Known infection with HIV, Hepatitis B or C